Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |